Eylea 2 MG/0.05 ML vial 0.05ML
Ended Awarded
- Contract number
- SPE2DB25FUJRX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,027
Award facts
- Contract value 100% obligated
- $5,027.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,027.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml vials. The contract, with an ultimate completion date of September 25, 2025, was issued without set-aside designation, allowing DMS to compete on its merits as a small business in the federal pharmaceutical marketplace. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide.
EYLEA, a biopharmaceutical product used in ophthalmology for treating retinal conditions, represents one of many specialty medications within the broader pharmaceutical portfolio that DMS supplies to military health facilities. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to DLA requisitions. This specific delivery order exemplifies the routine procurement operations under the SPE2DB program, through which the DLA leverages pre-established contracts to efficiently source necessary medical products for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FUJRX?
SPE2DB25FUJRX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FUJRX worth?
The government has obligated $5,027 on SPE2DB25FUJRX.
Is contract SPE2DB25FUJRX an order under another contract?
Yes. SPE2DB25FUJRX is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJRX competed?
The extent of competition for SPE2DB25FUJRX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award